Compare RBLX & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBLX | HLN |
|---|---|---|
| Founded | 2006 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8B | 43.7B |
| IPO Year | 2020 | N/A |
| Metric | RBLX | HLN |
|---|---|---|
| Price | $68.34 | $10.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 1 |
| Target Price | ★ $121.77 | N/A |
| AVG Volume (30 Days) | ★ 11.9M | 7.6M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,225,052,000.00 | N/A |
| Revenue This Year | $70.92 | $1.62 |
| Revenue Next Year | $16.76 | $4.39 |
| P/E Ratio | ★ N/A | $49.05 |
| Revenue Growth | ★ 15.94 | N/A |
| 52 Week Low | $50.10 | $8.71 |
| 52 Week High | $150.59 | $11.42 |
| Indicator | RBLX | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 40.26 |
| Support Level | $60.12 | $9.59 |
| Resistance Level | $75.41 | $11.35 |
| Average True Range (ATR) | 4.35 | 0.16 |
| MACD | 0.63 | -0.07 |
| Stochastic Oscillator | 40.76 | 15.71 |
Roblox operates a free-to-play online video game platform with nearly 150 million daily active users. This platform has spawned a virtual universe and a Roblox economy based on the Robux currency. The platform houses millions of games from a wide range of creators—spanning from young gamers themselves to professional development studios. Roblox offers creators the tools, publishing abilities, and platform for their games, enabling anyone to create a game. Creators earn money when gamers make optional in-game purchases within their games and by offering space for real-world advertising, and Roblox earns revenue primarily by taking a cut of these earnings.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.